A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one ...

Can’t breathe without your nasal spray? You’re not alone. But here’s why that quick fix can cause long-term harm.

The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...

The PL-14 Allergy Blocker, designed as a mucoadhesive nasal gel spray, aims to provide a physical ... along with ongoing development of its Trap and Target™ technology for nasal delivery of ...

ARS Pharmaceuticals has a recently launched needle-free epinephrine product for allergic reactions, neffy. See why I rate ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful ...

Unlike older medications that target serotonin – a “feel-good” chemical in the brain – the ketamine-based nasal spray works ...

The drug delivery method has been patented by the duo. The researcher duo explained in a press release that through a nasal spray, the nanoparticles in the medication reach the brain tumours.

The Asthma and Allergy Foundation released its annual Allergy Capitals list in March. The report uses data from the 100 most-populated metropolitan areas in the country on tree, grass, and weed pollen ...

Winter: Most people find their allergies dormant during the winter months because most plants don't pollinate during winter.

A novel approach to treating depression derived from a popular club drug offers hope to tens of thousands of Australians ...

A controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression.